Pharmafile Logo
Pharmafocus logo
Advanced Search

neurological disorders

Showing 5 posts of 5 posts found.

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025
Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …

News
milad-fakurian-58z17lnvs4u-unsplash_2

Autifony announces global license and collaboration agreement with Jazz Pharmaceuticals

November 14, 2023
Business Services Autifony, Neurology, collaboration, jazz pharmaceuticals, neurological disorders

Autifony Therapeutics has announced that it has entered an exclusive global licensing agreement with Jazz Pharmaceuticals for up to $770.5m, …

News

Forging a path forward in neurological disorders

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …

Feature
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!

News
handshake

Allergan to partner with Heptares in Alzheimer’s disease collaboration

April 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments

Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026